PMC8276647_01
Two days after sclerotherapy, with telangiectatic matting .
jvb-19-e20190159-g01-en.jpg
PMC8276647_01_jvb-19-e20190159-g01-en.jpg
gf0100
She developed a large expanse of telangiectatic matting (approximately 10 x 15 cm) in the area surrounding the vessels that had been treated, about 2 days after the procedure (Figure 1).
Unsatisfactory results after attempt to treat with intense pulsed light.
jvb-19-e20190159-g02-en.jpg
PMC8276647_01_jvb-19-e20190159-g02-en.jpg
gf0200
In the opinions of the same evaluator and of the patient, there was no more than mild attenuation of the condition (Figure 2).
Appearance after 1 week using brimonidine tartrate.
jvb-19-e20190159-g03-en.jpg
PMC8276647_01_jvb-19-e20190159-g03-en.jpg
gf0300
After 7 days of regular use of this medication, considerable improvement was observed (Figure 3).
Result after 2 weeks using brimonidine tartrate.
jvb-19-e20190159-g04-en.jpg
PMC8276647_01_jvb-19-e20190159-g04-en.jpg
gf0400
A joint decision was taken to continue applying the medication for a further 7 days, with very satisfactory results (Figure 4).
Follow-up, 6 months after appearance of telangiectatic matting.
jvb-19-e20190159-g05-en.jpg
PMC8276647_01_jvb-19-e20190159-g05-en.jpg
gf0500
The patient has been in clinical follow-up for 6 months (Figure 5) and no rebound effect has been observed to date.